Fairlie DP - Search Results

1

Structures of peptide agonists for human protease activated receptor 2.

Stoermer MJ, Flanagan B, Beyer RL, Madala PK, Fairlie DP. Stoermer MJ, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2012 Jan 15;22(2):916-9. doi: 10.1016/j.bmcl.2011.12.029. Epub 2011 Dec 13. Bioorg Med Chem Lett. 2012. PMID: 22209488

2

Flavones are inhibitors of HIV-1 proteinase.

Brinkworth RI, Stoermer MJ, Fairlie DP. Brinkworth RI, et al. Among authors: fairlie dp. Biochem Biophys Res Commun. 1992 Oct 30;188(2):631-7. doi: 10.1016/0006-291x(92)91103-w. Biochem Biophys Res Commun. 1992. PMID: 1445308

3

Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.

Wong AK, Finch AM, Pierens GK, Craik DJ, Taylor SM, Fairlie DP. Wong AK, et al. Among authors: fairlie dp. J Med Chem. 1998 Aug 27;41(18):3417-25. doi: 10.1021/jm9800651. J Med Chem. 1998. PMID: 9719594

4

Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP, Taylor SM. Finch AM, et al. Among authors: fairlie dp. J Med Chem. 1999 Jun 3;42(11):1965-74. doi: 10.1021/jm9806594. J Med Chem. 1999. PMID: 10354404

5

Protease inhibitors: current status and future prospects.

Leung D, Abbenante G, Fairlie DP. Leung D, et al. Among authors: fairlie dp. J Med Chem. 2000 Feb 10;43(3):305-41. doi: 10.1021/jm990412m. J Med Chem. 2000. PMID: 10669559 Review. No abstract available.

6

Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.

Fairlie DP, Tyndall JD, Reid RC, Wong AK, Abbenante G, Scanlon MJ, March DR, Bergman DA, Chai CL, Burkett BA. Fairlie DP, et al. J Med Chem. 2000 Apr 6;43(7):1271-81. doi: 10.1021/jm990315t. J Med Chem. 2000. PMID: 10753465

7

Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.

Tyndall JD, Reid RC, Tyssen DP, Jardine DK, Todd B, Passmore M, March DR, Pattenden LK, Bergman DA, Alewood D, Hu SH, Alewood PF, Birch CJ, Martin JL, Fairlie DP. Tyndall JD, et al. Among authors: fairlie dp. J Med Chem. 2000 Sep 21;43(19):3495-504. doi: 10.1021/jm000013n. J Med Chem. 2000. PMID: 11000004

8

Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors.

Leung D, Schroder K, White H, Fang NX, Stoermer MJ, Abbenante G, Martin JL, Young PR, Fairlie DP. Leung D, et al. Among authors: fairlie dp. J Biol Chem. 2001 Dec 7;276(49):45762-71. doi: 10.1074/jbc.M107360200. Epub 2001 Oct 1. J Biol Chem. 2001. PMID: 11581268 Free article.

9

Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.

Glenn MP, Pattenden LK, Reid RC, Tyssen DP, Tyndall JD, Birch CJ, Fairlie DP. Glenn MP, et al. Among authors: fairlie dp. J Med Chem. 2002 Jan 17;45(2):371-81. doi: 10.1021/jm010414i. J Med Chem. 2002. PMID: 11784141

10

Regioselective synthesis of antiparallel loops on a macrocyclic scaffold constrained by oxazoles and thiazoles.

Singh Y, Stoermer MJ, Lucke AJ, Glenn MP, Fairlie DP. Singh Y, et al. Among authors: fairlie dp. Org Lett. 2002 Oct 3;4(20):3367-70. doi: 10.1021/ol026463m. Org Lett. 2002. PMID: 12323020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters